| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $910.5M | $444.7M | $397.6M |
| YoY Revenue Growth % | +104.7% | +11.9% | — |
| Gross Profit | — | $377.1M | — |
| Gross Margin % | — | 84.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $114.1M | $51.3M | $124.2M |
| Operating Margin % | 12.5% | 11.5% | 31.2% |
| Net Income (GAAP) | $12.9M | $13.7M | $145.7M |
| EBITDA (Normalized) | $161.6M | $62.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $124.5M | $41.4M | $79.0M |
| Capital Expenditures (CapEx) | $59.4M | $13.5M | — |
| Free Cash Flow (FCF) | $65.1M | $27.9M | $79.0M |
| FCF Margin % | 7.2% | 6.3% | 19.9% |
| Return on Invested Capital (ROIC %) | 11.1% | 4.7% | — |
| Cash & Short-Term Equivalents | $125.2M | $41.8M | — |
| Total Debt (Short + Long Term) | $833.6M | $831.6M | — |
| Total Stockholders' Equity | $101.1M | $69.3M | — |